Ildong Pharmaceutical Co., Ltd. (249420.KS)
KRW 11350.0
(-5.42%)
KRW 11350.0
(-5.42%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 600.75 Billion | 637.71 Billion | 560.13 Billion | 561.84 Billion | 517.46 Billion | 503.9 Billion |
| Cost of Revenue | 393.21 Billion | 401.37 Billion | 340.69 Billion | 323.43 Billion | 285.11 Billion | 248.75 Billion |
| Gross Profit | 207.53 Billion | 236.34 Billion | 219.43 Billion | 238.41 Billion | 232.35 Billion | 255.15 Billion |
| Operating Expenses | 260.95 Billion | 309.67 Billion | 273.81 Billion | 231.78 Billion | 233.72 Billion | 226.81 Billion |
| Selling, General and Administrative Expenses | 165.93 Billion | 115.07 Billion | 95.38 Billion | 96.53 Billion | 102.85 Billion | 97.22 Billion |
| Research and Development Expenses | 95.01 Billion | 109.89 Billion | 96.52 Billion | 60.18 Billion | 48.49 Billion | 46.45 Billion |
| Other Expenses | 1.91 Billion | 84.71 Billion | 81.91 Billion | 75.06 Billion | 82.37 Billion | 1.47 Billion |
| Cost and Expenses | 654.17 Billion | 711.04 Billion | 614.51 Billion | 555.21 Billion | 518.84 Billion | 475.56 Billion |
| Operating Income | -53.41 Billion | -73.33 Billion | -54.37 Billion | 6.63 Billion | -1.25 Billion | 28.34 Billion |
| Interest Expense | 14.72 Billion | 9.78 Billion | 10.55 Billion | 4.66 Billion | 5.22 Billion | 3.58 Billion |
| Income Tax Expense | -13.31 Billion | 22.34 Billion | -40.23 Billion | 3.29 Billion | -9.19 Billion | 3.71 Billion |
| Earnings before Tax | -94.27 Billion | -119.82 Billion | -141.2 Billion | -9.72 Billion | -22.63 Billion | 16.43 Billion |
| Net Income | -78.92 Billion | -142.16 Billion | -100.96 Billion | -13.01 Billion | -13.44 Billion | 12.72 Billion |
| Earnings Per Share Basic | -2920.01 | -5396.73 | -4244.99 | -547.34 | -565.08 | 534.63 |
| Earnings Per Share Diluted | -2920.01 | -5396.73 | -4244.99 | -547.34 | -565.08 | 534.29 |
| Weighted Average Shares Outstanding | 27.03 Million | 26.34 Million | 23.78 Million | 23.78 Million | 23.79 Million | 23.79 Million |
| Weighted Average Shares Outstanding (Diluted) | 27.03 Million | 26.34 Million | 23.78 Million | 23.78 Million | 23.79 Million | 23.8 Million |
| Gross Margin | 0.35 | 0.37 | 0.39 | 0.42 | 0.45 | 0.51 |
| EBIT Margin | -0.09 | -0.07 | -0.04 | 0.06 | 0.05 | 0.11 |
| Profit Margin | -0.13 | -0.22 | -0.18 | -0.02 | -0.03 | 0.03 |
| EBITDA | -51.22 Billion | -80.49 Billion | -101.33 Billion | 22.6 Billion | 10.51 Billion | 50.75 Billion |
| Earnings Before Tax Margin | -0.09 | -0.11 | -0.10 | 0.01 | -0.00 | 0.06 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 155.94 Billion | 152.14 Billion | 151.09 Billion | 600.75 Billion | 151.08 Billion | 149.53 Billion |
| Cost of Revenue | - | 95.46 Billion | 93.96 Billion | 393.21 Billion | 98.19 Billion | 99.7 Billion |
| Gross Profit | 155.94 Billion | 56.68 Billion | 57.13 Billion | 207.53 Billion | 52.88 Billion | 49.82 Billion |
| Operating Expenses | 152.34 Billion | 56.14 Billion | 57.02 Billion | 260.95 Billion | 55.75 Billion | -66.87 Billion |
| Selling, General and Administrative Expenses | - | 45.36 Billion | 40.6 Billion | - | 36.47 Billion | 66.87 Billion |
| Research and Development Expenses | - | 10.77 Billion | 16.42 Billion | - | 19.27 Billion | 24.32 Billion |
| Other Expenses | -152.34 Billion | -152.65 Billion | -151 Billion | 1.91 Billion | 316.28 Million | -133.74 Billion |
| Cost and Expenses | 152.34 Billion | 151.6 Billion | 150.99 Billion | 654.17 Billion | 153.94 Billion | 99.7 Billion |
| Operating Income | 3.6 Billion | 547.88 Million | 106.08 Million | -53.41 Billion | -2.86 Billion | -17.04 Billion |
| Interest Expense | - | - | 4.11 Billion | 14.72 Billion | 2.68 Billion | 5.55 Billion |
| Income Tax Expense | 2 Billion | 2.26 Billion | 4.39 Billion | -13.31 Billion | -10.46 Billion | 503.39 Million |
| Earnings before Tax | -7.38 Billion | -1.9 Billion | 2.48 Billion | -94.27 Billion | -9.67 Billion | -45.99 Billion |
| Net Income | -9.39 Billion | -3.23 Billion | -833.32 Million | -78.92 Billion | 1.41 Billion | -46.02 Billion |
| Earnings Per Share Basic | -408.48 | -115.96 | -29.83 | - | 50.69 | -1710.92 |
| Earnings Per Share Diluted | -408.48 | -115.96 | -29.83 | - | 50.69 | -1710.92 |
| Weighted Average Shares Outstanding | 22.99 Million | 27.93 Million | 27.93 Million | 27.03 Million | 27.93 Million | 26.89 Million |
| Weighted Average Shares Outstanding (Diluted) | 22.99 Million | 27.93 Million | 27.93 Million | 27.03 Million | 27.93 Million | 26.89 Million |
| Gross Margin | 1.00 | 0.37 | 0.38 | 0.35 | 0.35 | 0.33 |
| EBIT Margin | 0.02 | 0.05 | 0.04 | - | 0.03 | 0.33 |
| Profit Margin | -0.06 | -0.02 | -0.01 | -0.13 | 0.01 | -0.31 |
| EBITDA | 3.6 Billion | 7.18 Billion | 6.38 Billion | - | 3.82 Billion | 49.82 Billion |
| Earnings Before Tax Margin | 0.02 | 0.00 | 0.00 | -0.09 | -0.02 | -0.11 |
GMTD
601100
FUR
600219
688366
BETS-B